(Q57974104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

New water-soluble carbamate ester derivatives of resveratrol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Massimo Carraro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michele Azzolini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Lucia Biasutto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Cristina Paradisi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mario Zoratti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

15900-15917

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

20 February 2020

copyright license

start time

1 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Resveratrol: a multitargeted agent for age-associated chronic diseases.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Mitochondrial effects of plant-made compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol and health: the starting point

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol and calcium signaling: molecular mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Novel insights of dietary polyphenols and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol: new avenues for a natural compound in neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

mTOR: more targets of resveratrol?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Metabolites and tissue distribution of resveratrol in the pig

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Distribution of [3H]trans-resveratrol in rat tissues following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Pharmacokinetics and tissue distribution of pterostilbene in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Bioavailability of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol transport and metabolism by human intestinal Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Human, rat, and mouse metabolism of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Hepatic Glucuronidation of Resveratrol: Interspecies Comparison of Enzyme Kinetic Profiles in Human, Mouse, Rat, and Dog

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol metabolism in a non-human primate, the grey mouse lemur (Microcebus murinus), using ultra-high-performance liquid chromatography-quadrupole time of flight

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Anti-estrogenic activity of a human resveratrol metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol-sulfates provide an intracellular reservoir for generation of parent resveratrol, which induces autophagy in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol: challenges in translation to the clinic--a critical discussion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Development and evaluation of emulsion-liposome blends for resveratrol delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Drug loading in Pluronic® micelles made by solvent casting and equilibrium methods using resveratrol as a model drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Improvements of cellular stress response on resveratrol in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives: the second Symposium on Innovative Polymers for Controlled Delivery Suzhou, China, 11–14 September 2012 .

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Nanoencapsulation of quercetin and resveratrol into elastic liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Enhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Prodrugs of quercetin and resveratrol: a strategy under development

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Improving the efficacy of plant polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Carbamate ester derivatives as potential prodrugs of the presynaptic dopamine autoreceptor agonist (-)-3-(3-hydroxyphenyl)-N-propylpiperidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

PEGylation, successful approach to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

The impact of PEGylation on biological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Advances in PEGylation of important biotech molecules: delivery aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Pharmacokinetic consequences of pegylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Acetal Derivatives as Prodrugs of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted rat intestinal segments

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Apical GLUT2: a major pathway of intestinal sugar absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Stimulation of fructose transport across the intestinal brush-border membrane by PMA is mediated by GLUT2 and dynamically regulated by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Oral drug delivery utilizing intestinal OATP transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

OATP transporter-mediated drug absorption and interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

OCTN cation transporters in health and disease: role as drug targets and assay development

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Qualitative structure-metabolism relationships in the hydrolysis of carbamates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Determination of quercetin and resveratrol in whole blood--implications for bioavailability studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191015900

Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl- and N,N-dialkyl-carbamate esters of entacapone

21 January 2018

1 reference

12 December 2020

Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway

1 reference

12 December 2020

Comparison of the antioxidant and transmembrane permeative activities of the different Polygonum cuspidatum extracts in phospholipid-based microemulsions

1 reference

12 December 2020

Evaluation of the Stability and Antioxidant Activity of Nanoencapsulated Resveratrol during in Vitro Digestion

1 reference

12 December 2020

Resveratrol nanosuspensions: interaction of preservatives with nanocrystal production

1 reference

12 December 2020

Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol

1 reference

12 December 2020

Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability

1 reference

12 December 2020

Synthesis and Antitumor Activity of Duocarmycin Derivatives

1 reference

12 December 2020

10.3390/MOLECULES191015900

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25275336%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

25275336

1 reference